The invention features quaternary ammonium compounds of formula I, described herein, and their use in treating asthma, chronic obstructive pulmonary disorder, allergic rhinitis, and infectious rhinitis.

 
Web www.patentalert.com

< 3,4-dihydro-(1H)quinazolin-2-one compounds as CSBP/p38 kinase inhibitors

< Peptide derivatives

> Antibodies against secreted protein HTEBYII

> Wnt-regulated cytokine-like polypeptide and nucleic acids encoding same
~ 00212